Anticipating The Powerful Advance In Gilead Sciences (GILD)
by Mike Paulenoff
October 30, 2022 • 4:32 PM EDT
Back on August 29, Mike Paulenoff alerted MPTrader members to his excitement about the potential for a powerful advance in Gilead Sciences (GILD), writing:
For two years, GILD has been traversing a wide (24%) range between 57-59 on the low side and 70-72 on the high side (see my attached Daily Chart). Every time GILD sinks into the vicinity of 60, it becomes relatively cheap within the range (57 stop) ahead of a traverse towards 70-72... If you are a VERY PATIENT investor who does not mind tying up money for an extended period of time, then you are risking a close under 56.50 to "be there" for the run to and above 69.00-70.00, and thereafter, towards a challenge of the upper boundary zone from 83 to 87, where GILD either will rocket into a new bull leg, or fail miserably.
My sense from the very BIG picture structural setup since 2010 is that since 2017 GILD has been biding time ahead of a forthcoming VERY BULLISH direction price catalyst (or catalysts) that will propel the stock out of its rangebound funk... Last is 62.56.
Fast-forward to last week in which indeed a catalyst unleashed GILD's bullish potential. It turned out to be a Q3 Earnings Report that far exceeded Wall Street's expectations, and as such, triggered an extremely positive investor reaction that propelled the stock above a 2-1/2 year resistance plateau from 72 to 74, toward Mikes intermediate-term target zone of 83 to 87.
GILD closed at 79.27 on Friday, a full 27% above its price when Mike first alerted MPTrader members on August 29.
What's next for GILD and other names and ETFs in the Biotech and Healthcare space? Join Mike and MPTrader members for their constant intraday market discussions about individual stocks, ETFs, Macro Indices, Commodities, Crypto, and much more, especially during the forthcoming consequential Fed Week!
Mike Paulenoff is the author of MPTrader.com, a real-time diary of his technical analysis & trade alerts
on
ETFs for precious metals, energy, currencies, and an array of equity indices and sectors, including
international
markets, plus key ETF component stocks in sectors like technology, mining, and banking.
Sign up for a Free 7-day Trial!
More Top Calls From Mike
Last Tuesday afternoon, hours before CAVA (Cava Group) was scheduled to report Earnings, this is what I posted for MPTrader members:CAVA reports Earnings after today's close. Approaching the news, CAVA is circling 61, a full 40% beneath its April 2026 high at 98.79, amid an unconfirmed new corrective low at 60.21 yesterday (8/10/26), leaving CAVA positioned for a "buy-the-news" setup (the opposite of a sell-the-news setup in a name that is up 30% to 40% approaching Earnings).
Good Sunday Afternoon, MPTraders! Last Thursday afternoon, ahead of AAPL's Earnings, this is what we discussed about the stock's probable price path in reaction to the news:Unless AAPL produces something extraordinary, or otherwise announces some unknown bullish catalyst, my pattern work has a very difficult time expecting anything other than a "best-case" sell-the-news scenario in reaction to Earnings. I can make a compelling argument that the upleg from the 6/26/26 low at 273.33 to the 7/29/26 ATH at 344.
XOM (Exxon Mobil)-- Back on May 19, 2026, a fellow MPTrader member requested an update on XOM. This is what we discussed at that time:My attached Daily Chart setup shows my preferred scenario calling for a near-term peak of the current upmove from the 4/17 low at 141.97 to a target zone from 162 to 165, followed by a rollover and press lower that revisits and possibly breaks the 41/7 low, which also will complete the larger corrective process from the 3/30/26 ATH at 176.41.
Pharma Update: MRK and LLYOn Wednesday (6/24/26), this is what we discussed about MRK:MRK as well, which we see on my attached Daily Chart exhbits a VERY BULLISH technical setup-- quite the opposite of beleaguered PFE. My pattern work argues that all of the price action from the 2/25/26 high at 125.14 represents a high-level bullish digestion period and pattern atop the major upleg from the May 2025 low at 73.31.
On January 2, 2026, this is what I posted about CAVA (Cava Group Casual Mediterranean Cuisine) to MPTrader members:After CAVA's meteoric climb from 29.00 in October 2023 to an ATH at 172.65 in November 2024, the stock rolled over into a relentless decline that hit its low at 43.
